Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P230044/S002

alfapump System

Sequana Medical NV · Decision date Dec 19, 2025

FDA DECISIONP230044/S002

What did the FDA approve?

FDA records P230044/S002 as a supplement to PMA P230044, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Dec 19, 2025.

FDA approval order statement

approval for a new mold release agent
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Gastroenterology, Urology
Decision date
Dec 19, 2025
FDA change category
Change Design/Components/Specifications/Material

FDA source record

Regulatory record facts

Identifier
P230044/S002
Regulatory pathway
PMA supplement
Product code
SDQ
Decision code
APPR
Decision date
Dec 19, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: alfapump System.

Product code
SDQ
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P230044/S002 received

    Application receipt date recorded by FDA.

  2. P230044/S002 · FDA decision

    Real-Time Process

Timeline entries are records held by MedtechLedger for P230044. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P230044

Product / regulatory recordCompanyPathwayDecision dateSource
alfapump SystemP230044/S003
Sequana Medical NVPMA supplementFeb 18, 2026FDA
alfapump SystemP230044/S004
Sequana Medical NVPMA supplementMay 5, 2026FDA
alfapump SystemP230044/S005
Sequana Medical NVPMA supplementMay 5, 2026FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Sequana Medical NV

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Kortrijksesteweg 1112, Sint-Denijs-Westrem, 9051

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records